Moviprep and Skin disorder - a phase IV clinical study of FDA data

Summary:

Skin disorder is reported as a side effect among people who take Moviprep (ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Mesalamine, and have Ulcerative colitis.

The phase IV clinical study analyzes which people have Skin disorder when taking Moviprep. It is created by eHealthMe based on reports of 3,148 people who have side effects when taking Moviprep from the FDA, and is updated regularly.

What is Moviprep?

Moviprep has active ingredients of ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate. It is often used in colonoscopy abnormal. eHealthMe is studying from 3,173 Moviprep users. Check the latest studies of Moviprep.

What is Skin disorder?

Skin disorder (skin disease) is found to be associated with 1,545 drugs and 1,450 conditions by eHealthMe. Check the latest studies of Skin disorder.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

3,148 people reported to have side effects when taking Moviprep.
Among them, 17 people (0.54%) have Skin disorder.

Among these 17 people:

How long have people been on Moviprep when they have Skin disorder? *

What is the gender of people who have Skin disorder when taking Moviprep? *

female: 100 %
male: 0.0 %

What is the age of people who have Skin disorder when taking Moviprep? *

What are other drugs people take besides Moviprep? *

What are other side effects people have besides Skin disorder? *

Headache (pain in head): 11 people, 64.71%
Hepatotoxicity (chemical-driven liver damage): 9 people, 52.94%
Insomnia (sleeplessness): 9 people, 52.94%
Fatigue (feeling of tiredness): 9 people, 52.94%
Liver Disorder (liver diseases): 9 people, 52.94%
Cholangitis Sclerosing (infection and obstruction of bile duct): 9 people, 52.94%
Nasopharyngitis (inflammation of the nasopharynx): 9 people, 52.94%
Nausea And Vomiting: 9 people, 52.94%
Fluid Retention (an abnormal accumulation of fluid in the blood): 9 people, 52.94%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 9 people, 52.94%

What are the existing conditions these people have? *

Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 9 people, 52.94%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 5 people, 29.41%
Psoriasis (immune-mediated disease that affects the skin): 5 people, 29.41%
Asthma: 2 people, 11.76%
Ocular Hyperaemia (an abnormally large amount of blood in eye): 1 person, 5.88%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Moviprep and have Skin disorder?

- Check whether Skin disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Moviprep:

Moviprep (3,173 reports)

Skin disorder treatments and more:

Skin disorder (41,532 reports)

How severe was Skin disorder and when was it recovered:

Skin disorder in Moviprep

Expand to all the drugs that have ingredients of ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate:

Skin disorder and drugs with ingredients of ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Moviprep:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Skin disorder:

Skin disorder (1,545 drugs)

Browse all the conditions that are associated with Skin disorder:

Skin disorder (1,450 conditions)

Related publications that referenced our studies

Moftah NH, Kamel AM, Attia HM, El-Baz MZ, El–Moty HM, "Skin diseases in patients with primary psychiatric conditions: a hospital based study", Journal of epidemiology and global health, 2013 Sep .
Moftah NH, Kamel AM, Attia HM, El-Baz MZ, El–Moty HM, "Skin diseases in patients with primary psychiatric conditions: a hospital based study", Journal of epidemiology and global health, 2013 Sep .

How the study uses the data?

The study uses data from the FDA. It is based on ascorbic acid; polyethylene glycol 3350; potassium chloride; sodium ascorbate; sodium chloride; sodium sulfate (the active ingredients of Moviprep) and Moviprep (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.